A Swiss pharmaceutical company is financing a Michigan study of the effectiveness of drug combinations in treating high blood pressure among diabetics. Basel, Switzerland-based Novartis AG is giving $440,000 for the research at Beaumont Hospitals in Royal…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




NovartisPharmaceutical industrySwitzerlandHypertensionBusiness

Read the original post:
Study tests blood pressure drugs for diabetics